In a commentary for Morning Consult, Virginia Ladd, President and Executive Director of the American Autoimmune Related Diseases Association (AARDA), emphasizes how critical it is that the patient perspective be front and center in discussions about how we measure and pay for value. Read the full article here.
In a commentary for the Health Affairs Blog, Rena M. Conti, PhD, and IVI Executive Director, Darius Lakdawalla, argue that advancing the science of value assessment requires new assessment tools that are transparent and incorporate the perspectives of patients and insurance plan enrollees. Read the full article here.
In a commentary for the Health Affairs Blog, IVI's Jeroen Jansen, Devin Incerti, and Mark Linthicum argue that, in order to move toward consensus on value assessment, the process for defining and measuring value must be transparent, collaborative, and iterative. IVI is taking the first steps towards consensus with the development of the Open-Source Value Project. [...]
IVI Director of Scientific Communications, Mark Linthicum, talked to Managed Healthcare Executive about how the Open-Source Value Project (OSVP) is going to change the way we approach value assessment and ultimately measure value in health care treatments and services. Read the full article here.
IVI Launches Groundbreaking Project Allowing Patients, Payers and Providers to Measure Value in Health Care
IVI’s “Open-Source Value Project” Develops Dynamic and Flexible Models to Help All Health Care Stakeholders Make Scientifically-Based Decisions about the Value of Treatments and Services; First Model, Released Today, is Focused on Rheumatoid Arthritis Treatments Los Angeles, CA (November 8, 2017) – The Innovation and Value Initiative (IVI) – a collaboration of academics, patient advocacy [...]
IVI’s Mark Linthicum in Morning Consult: Why Understanding Value is Central to True Health Care Reform
Mark Linthicum makes the case that value-based spending should be the focus of health care reform efforts in Washington, D.C. On September 13th health care stakeholders came together at the National Press Club to discuss better approaches to measuring value. Read Full Article Here
On September 13th, the Innovation and Value Initiative was proud to sponsor a special Health Affairs briefing in Washington, D.C. Over 200 of the country's most influential health care stakeholders and public policy thought leaders gathered to address the topic of value in health care. Focusing on "Understanding the Value of Innovations in Medicine," this [...]
In a new commentary for U.S. News and World Report, Jason Shafrin defines and elaborates on the field of precision medicine. Jason, IVI's Director of Research, illustrates how the United States is moving headlong into this new treatment approach. He notes some of the challenges while also emphasizing the unique hope precision medicine brings through [...]
In a recent post on the IVI-Sponsored Health Affairs blog series, Rachel Sachs provides an overview of the House of Representative's latest draft of the FDA user fee authorization bill. Sachs also examines changes in the bill from the earlier Senate markup, including incorporation of provisions from the bipartisan RACE Act and provides a possible [...]
In this month's Drug Topics, correspondent Kathleen Gannon Longo speaks with Jeremy Schafer about the potentially tremendous impact that value assessments will have on future patient reimbursement decisions. Focusing on Oncology treatment, Schafer describes some of the existing value frameworks in play as well as referencing the work being done by the IVI to employ [...]